In this episode of "Balancing the Future," hosts Dana Clemençon and Micah Schweitzer delve into revolutionary advancements in breast cancer screening and monitoring with researcher Ivana Domljanovic from the University of Fribourg. As breast cancer remains one of the most common and deadly cancers among women, the need for more effective monitoring and screening methods is urgent.
Ivana shares her groundbreaking work using nanotechnology and microRNAs to develop a point-of-care device that aims to enhance early detection and patient monitoring. Traditional methods like mammograms, while beneficial, can be uncomfortable and sometimes yield false positives, highlighting the need for innovation in this space.
Listeners will discover how Ivana's approach leverages DNA origami nanotechnology to identify dysregulated microRNAs, which are critical indicators of cancer. This novel method has the potential to deliver quick, cost-effective results, making screening more accessible, especially in under-resourced areas.
The episode also explores the future implications of this technology, including the possibility of at-home testing and its role in personalized medicine. Ivana envisions a world where routine blood tests could seamlessly incorporate cancer detection, revolutionizing patient care and outcomes.
Join us as we explore the intersection of science and technology in the fight against breast cancer and the exciting possibilities that lie ahead for early detection and effective treatment. Don't miss this enlightening conversation that could change the way we approach cancer screening and monitoring for good.
Listen to the episode now on your favorite streaming platform: Spotify, Apple Podcasts, YouTube.
Postdoctoral Researcher at the University of Fribourg
Dr. Ivana Domljanovic is a post-doctoral researcher at the University of Fribourg in Switzerland, where she is leading innovative research in breast cancer detection technology.
